These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9523549)

  • 1. GM1 ganglioside: in vivo and in vitro trophic actions on central neurotransmitter systems.
    Hadjiconstantinou M; Neff NH
    J Neurochem; 1998 Apr; 70(4):1335-45. PubMed ID: 9523549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-induced neurotransmitter deficits in neonatal rats are partially corrected by exogenous GM1 ganglioside.
    Hadjiconstantinou M; Yates AJ; Neff NH
    J Neurochem; 1990 Sep; 55(3):864-9. PubMed ID: 1696622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal hypoxia: early neurotransmitter responses and the consequences of treatment with GM1 ganglioside.
    Krajnc D; Wemlinger TA; Neff NH; Hadjiconstantinou M
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1299-305. PubMed ID: 7996438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of neuronal apoptotic death by neurotrophic agents and ganglioside GM1: insights and speculations regarding a common mechanism.
    Ferrari G; Greene LA
    Perspect Dev Neurobiol; 1996; 3(2):93-100. PubMed ID: 8826527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gangliosides and neurotrophic factors in neurodegenerative diseases: from experimental findings to clinical perspectives.
    Fusco M; Vantini G; Schiavo N; Zanotti A; Zanoni R; Facci L; Skaper SD
    Ann N Y Acad Sci; 1993 Sep; 695():314-7. PubMed ID: 8239303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GM1 Ganglioside Is A Key Factor in Maintaining the Mammalian Neuronal Functions Avoiding Neurodegeneration.
    Chiricozzi E; Lunghi G; Di Biase E; Fazzari M; Sonnino S; Mauri L
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32013258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gangliosides potentiate in vivo and in vitro effects of nerve growth factor on central cholinergic neurons.
    Cuello AC; Garofalo L; Kenigsberg RL; Maysinger D
    Proc Natl Acad Sci U S A; 1989 Mar; 86(6):2056-60. PubMed ID: 2928318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of GM1 ganglioside on neonatally neurotoxin induced degeneration of serotonin neurons in the rat brain.
    Jonsson G; Gorio A; Hallman H; Janigro D; Kojima H; Zanoni R
    Brain Res; 1984 Nov; 318(2):171-80. PubMed ID: 6093923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxic-ischemic damage and the neuroprotective effects of GM1 ganglioside.
    Leon A; Lipartiti M; Seren MS; Lazzaro A; Mazzari S; Koga T; Toffano G; Skaper SD
    Stroke; 1990 Nov; 21(11 Suppl):III95-7. PubMed ID: 2237992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GM1 ganglioside inhibits ischemic release of amino acid neurotransmitters from rat cortex.
    Phillis JW; O'Regan MH
    Neuroreport; 1995 Oct; 6(15):2010-2. PubMed ID: 8580429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM1 Ganglioside: Past Studies and Future Potential.
    Aureli M; Mauri L; Ciampa MG; Prinetti A; Toffano G; Secchieri C; Sonnino S
    Mol Neurobiol; 2016 Apr; 53(3):1824-1842. PubMed ID: 25762012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced restoration of striatal dopamine concentrations by combined GM1 ganglioside and neurotrophic factor treatments.
    Schneider JS; DiStefano L
    Brain Res; 1995 Mar; 674(2):260-4. PubMed ID: 7796105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with GM1 ganglioside increases rat spinal cord indole content.
    Hadjiconstantinou M; Neff NH
    Brain Res; 1986 Feb; 366(1-2):343-5. PubMed ID: 2421824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GM1 and the aged brain.
    Hadjiconstantinou M; Neff NH
    Ann N Y Acad Sci; 1998 Jun; 845():225-31. PubMed ID: 9668356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further studies on the effects of the GM1 ganglioside on the degenerative and regenerative features of mesostriatal dopamine neurons.
    Agnati LF; Fuxe K; Calza L; Goldstein M; Toffano G; Giardino L; Zoli M
    Acta Physiol Scand Suppl; 1984; 532():37-44. PubMed ID: 6594030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GM1 ganglioside partially rescues cultured dopaminergic neurons from MPP(+)-induced damage: dependence on initial damage and time of treatment.
    Stull ND; Schneider JS; Iacovitti L
    Brain Res; 1994 Mar; 640(1-2):308-15. PubMed ID: 7911728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM1 ganglioside enhances Ret signaling in striatum.
    Newburn EN; Duchemin AM; Neff NH; Hadjiconstantinou M
    J Neurochem; 2014 Aug; 130(4):541-54. PubMed ID: 24821093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson's Disease.
    Schneider JS; Seyfried TN; Choi HS; Kidd SK
    PLoS One; 2015; 10(12):e0143351. PubMed ID: 26629687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biologic role of ganglioside in neuronal differentiation--effects of GM1 ganglioside on human neuroblastoma SH-SY5Y cells.
    Lee MC; Lee WS; Park CS; Juhng SW
    J Korean Med Sci; 1994 Apr; 9(2):179-87. PubMed ID: 7986393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological characterization of nerve growth factor and/or monosialoganglioside GM1 effects on cholinergic markers in the adult lesioned brain.
    Garofalo L; Cuello AC
    J Pharmacol Exp Ther; 1995 Feb; 272(2):527-45. PubMed ID: 7853166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.